ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents (Q22241496)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents	scientific article

Statements

scholarly article

0 references

ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents (English)

0 references

attention deficit hyperactivity disorder

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

James M. Perrin

object named as

James Perrin

12

author given names

James

author last names

Perrin

1 reference

7 February 2023

13

object named as

Karen Pierce

author given names

Karen

author last names

Pierce

1 reference

7 February 2023

author name string

Mark Wolraich

3

author given names

Mark

author last names

Wolraich

1 reference

7 February 2023

Lawrence Brown

4

author given names

Lawrence

author last names

Brown

1 reference

7 February 2023

Ronald T Brown

5

author given names

Ronald T

author last names

Brown

1 reference

7 February 2023

George DuPaul

6

author given names

George

author last names

DuPaul

1 reference

7 February 2023

Marian Earls

7

author given names

Marian

author last names

Earls

1 reference

7 February 2023

Heidi M Feldman

8

author given names

Heidi M

author last names

Feldman

1 reference

7 February 2023

Theodore G Ganiats

9

author given names

Theodore G

author last names

Ganiats

1 reference

7 February 2023

Beth Kaplanek

10

author given names

Beth

author last names

Kaplanek

1 reference

7 February 2023

Bruce Meyer

11

author given names

Bruce

author last names

Meyer

1 reference

7 February 2023

Michael Reiff

14

author given names

Michael

author last names

Reiff

1 reference

7 February 2023

Martin T Stein

15

author given names

Martin T

author last names

Stein

1 reference

7 February 2023

Susanna Visser

16

author given names

Susanna

author last names

Visser

1 reference

7 February 2023

language of work or name

0 references

publication date

November 2011

0 references

0 references

128

0 references

1007-22

0 references

5

0 references

Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

19 March 2017

A review of the evidence for the medical home for children with special health care needs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

19 March 2017

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

19 March 2017

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

19 March 2017

Prevalence and Correlates of ADHD Symptoms in the National Health Interview Survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

6 April 2017

A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

12 September 2017

Predicting attention-deficit/hyperactivity disorder and oppositional defiant disorder from preschool diagnostic assessments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

12 September 2017

The enhanced medical home: the pediatric standard of care for medically underserved children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

12 September 2017

Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

12 September 2017

Approaching ADHD as a chronic condition: implications for long-term adherence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

12 September 2017

Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

12 September 2017

Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

12 September 2017

Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

12 September 2017

Clinical and parental assessment of sleep in children with attention-deficit/hyperactivity disorder referred to a pediatric sleep medicine center

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

12 September 2017

The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

12 September 2017

Sleep problems in children with attention-deficit/hyperactivity disorder: prevalence and the effect on the child and family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

27 September 2017

National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

27 September 2017

More than the terrible twos: the nature and severity of behavior problems in clinic-referred preschool children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

27 September 2017

Empirically supported psychosocial treatments for attention deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

27 September 2017

Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

30 May 2018

Further evidence of unique developmental phenotypic correlates of pediatric bipolar disorder: findings from a large sample of clinically referred preadolescent children assessed over the last 7 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

30 May 2018

Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

30 May 2018

Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

30 May 2018

Scope of health care benefits for children from birth through age 26.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Enhancing pediatric mental health care: report from the American Academy of Pediatrics Task Force on Mental Health. Introduction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Sudden death and use of stimulant medications in youths.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

New insights into the comorbidity between ADHD and major depression in adolescent and young adult females

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Adolescent outcome of ADHD: impact of childhood conduct and anxiety disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Snoring, sleep quality, and sleepiness across attention-deficit/hyperactivity disorder subtypes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Improving primary care for patients with chronic illness: the chronic care model, Part 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Improving primary care for patients with chronic illness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

A DSM-IV-referenced screening instrument for preschool children: the Early Childhood Inventory-4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

Parent reported preschool attention deficit hyperactivity: measurement and validity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500647

29 November 2018

ECI-4 screening of attention deficit-hyperactivity disorder and co-morbidity in Mexican preschool children: preliminary results

1 reference

https://pubmed.ncbi.nlm.nih.gov/22003063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/22003063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/22003063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classifying recommendations for clinical practice guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/22003063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22003063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/22003063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomized, controlled trial with a community sample

1 reference

https://pubmed.ncbi.nlm.nih.gov/22003063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/22003063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of attention-deficit/hyperactivity disorder symptom subtypes in Ukrainian schoolchildren

1 reference

https://pubmed.ncbi.nlm.nih.gov/22003063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children

1 reference

https://pubmed.ncbi.nlm.nih.gov/22003063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1542/PEDS.2011-2654

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22241496&oldid=1951656033"